Robert B. Jones

Insider Reports History

Entity
Individual
Location
C/O Acura Pharmaceuticals, Inc., 616 N North Court, Palatine, IL
Signature
/s/ Robert B. Jones
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert B. Jones:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACURA PHARMACEUTICALS, INC President & CEO Common Stock 644K Nov 20, 2023 Direct
ACURA PHARMACEUTICALS, INC President & CEO Restricted Stock Unit (2017 Plan) 40K Jan 3, 2023 Direct
ACURA PHARMACEUTICALS, INC President & CEO Restricted Stock Unit (2021 Plan) 0 Nov 20, 2023 Direct

Insider Reports Filed by Robert B. Jones

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACUR ACURA PHARMACEUTICALS, INC Nov 20, 2023 2 $0 4 Nov 20, 2023 President & CEO
ACUR ACURA PHARMACEUTICALS, INC Jan 3, 2023 2 $0 4 Jan 5, 2023 President & CEO
ACUR ACURA PHARMACEUTICALS, INC Aug 3, 2022 3 $0 4 Aug 5, 2022 President & CEO
ACUR ACURA PHARMACEUTICALS, INC Mar 16, 2022 1 $0 4 Mar 18, 2022 President & CEO